STOCK TITAN

EQRx to Participate in the Jefferies 2022 London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

EQRx, a pioneering pharmaceutical company, will present a fireside chat at the Jefferies 2022 London Healthcare Conference on November 17, 2022, at 1:30 PM GMT / 8:30 AM EST. This event highlights EQRx's commitment to providing innovative medicines at lower costs. Interested parties can access a live and archived webcast on the company's website under the News & Events section. Since its launch in January 2020, EQRx has aimed to disrupt high-cost drug categories through strategic partnerships and advanced technology.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at substantially lower prices, today announced that management will participate in a fireside chat at the Jefferies 2022 London Healthcare Conference on Thursday, November 17, 2022, at 1:30 p.m. GMT / 8:30 a.m. EST.

A live and archived webcast of the fireside chat will be available by visiting the News & Events section of EQRx’s website, and selecting Events & Presentations, at investors.eqrx.com.

About EQRx
EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at substantially lower prices. Launched in January 2020, EQRx is purpose-built, at scale, with a growing catalog of medicines in development in high-cost drug categories and emerging partnerships with leading payers and health systems. Leveraging cutting-edge science and technology and strategic partnerships with stakeholders from across the healthcare system, EQRx aims to provide innovative, patent-protected medicines more efficiently and cost-effectively than ever before. To learn more, visit www.eqrx.com and follow us on social media: Twitter: @EQRx_US LinkedIn, Instagram: @eqrxinc.

EQRx™ and Remaking Medicine™ are trademarks of EQRx.

EQRx Contacts:

Media:
Dan Budwick
1AB
dan@1abmedia.com

Investors:
investors@eqrx.com


FAQ

When is EQRx's fireside chat at the Jefferies 2022 London Healthcare Conference?

EQRx's fireside chat is scheduled for November 17, 2022, at 1:30 PM GMT / 8:30 AM EST.

How can I access the webcast for EQRx's conference participation?

The webcast can be accessed live and archived via the News & Events section on EQRx's website.

What is EQRx's mission as a pharmaceutical company?

EQRx is committed to developing and delivering innovative medicines at substantially lower prices.

When was EQRx founded?

EQRx was launched in January 2020.

What strategies does EQRx use to reduce drug costs?

EQRx uses advanced technology, strategic partnerships, and a focus on high-cost drug categories to reduce medicine costs.

Eqrx Inc

NASDAQ:EQRX

EQRX Rankings

EQRX Latest News

EQRX Stock Data

1.14B
441.87M
11.14%
68.24%
2.04%
Biotechnology
Healthcare
Link
United States
Cambridge